Real World Data

Data and Digital takeaways from J.P. Morgan 2020


Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development, wrote a very succinct summary of the core topics covered at J.P. Morgan 2020. We’re excited to see the continued momentum behind these digital trends and how we’re enabling Sponsors to take advantage of Real World Data, Machine Learning and so much more through…

Read More

FDA requires more postmarket data to keep certain devices on the market


Medical Design & Outsourcing has published an article regarding FDA’s recent announcement require Medical Device manufacturers to provide more Real World Evidence for certain premarket approvals or risk losing those approvals. To read the entire article, click the button below. Continue Reading The Entire Article

Read More